1 |
Uppal D, Henry Z, Al-osaimi A, Saad W, Caldwell S. Management of Gastric Varices. Curr Hepatology Rep 2014;13:208-17. [DOI: 10.1007/s11901-014-0232-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
2 |
Komori K, Kubokawa M, Ihara E, Akahoshi K, Nakamura K, Motomura K, Masumoto A. Prognostic factors associated with mortality in patients with gastric fundal variceal bleeding. World J Gastroenterol 2017; 23(3): 496-504 [PMID: 28210086 DOI: 10.3748/wjg.v23.i3.496] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
|
3 |
Tian NN, Xiang HL, Lv HM, Wang F, Nie XH. Factors affecting re-bleeding after injection of cyanoacrylate for gastric varices. Shijie Huaren Xiaohua Zazhi 2013; 21(10): 908-914 [DOI: 10.11569/wcjd.v21.i10.908] [Reference Citation Analysis]
|
4 |
Tang RSY, Kyaw MH, Teoh AYB, Lui RNS, Tse YK, Lam TYT, Chan SL, Wong VWS, Wu JCY, Lau JYW, Sung JJY. Endoscopic ultrasound-guided cyanoacrylate injection to prevent rebleeding in hepatocellular carcinoma patients with variceal hemorrhage. J Gastroenterol Hepatol 2020;35:2192-201. [PMID: 32602261 DOI: 10.1111/jgh.15168] [Reference Citation Analysis]
|
5 |
Mosli MH, Aljudaibi B, Almadi M, Marotta P. The safety and efficacy of gastric fundal variceal obliteration using N-butyl-2-cyanoacrylate; the experience of a single canadian tertiary care centre. Saudi J Gastroenterol. 2013;19:152-159. [PMID: 23828744 DOI: 10.4103/1319-3767.114508] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|